Physician profile
Marshall Bernard Marcus
NPI 1609160563
$62,710.06
in general payments reported to CMS, 2019-2025
51 companies · $7,870 in 2025
The $7,870 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $4,709 · 2021: $4,516 · 2022: $15K · 2023: $10K · 2024: $3,633 · 2025: $7,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $4,807 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Education: $9.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,075.57 |
| Travel and Lodging | $4,807.12 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Education | $9.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $31,025.79 | 2019-2024 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $6,810.34 | 2019-2025 | Farapulse, Watchman Access System, Emblem Mri S-Icd |
| Abbott Laboratories | $5,271.01 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic, INC. | $5,080.63 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $2,685.41 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,858.57 | 2019-2022 | |
| Biosense Webster, INC. | $1,605.09 | 2019-2025 | Carto 3, Na, Octaray Mapping Catheter |
| Atricure, INC. | $1,237.52 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $1,007.74 | 2019-2025 | Camzyos, Eliquis |
| Acutus Medical, INC. | $994.94 | 2019-2021 | |
| Pfizer INC. | $668.50 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.57 | 2019-2025 | Jardiance |
| Philips North America LLC | $480.74 | 2020-2025 | Igt Devices Undivided, Extended Holter, (Am5) Lead Management |
| Impulse Dynamics (USA) INC. | $431.18 | 2021-2025 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $343.97 | 2019-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $324.37 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $242.16 | 2020-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $213.19 | 2022-2024 | |
| Cardiva Medical, INC. | $186.70 | 2021-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Shockwave Medical, INC | $168.19 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.24 | 2019-2024 | Lifevest |
| Itamar Medical INC | $153.99 | 2022 | |
| Merck Sharp & Dohme LLC | $145.24 | 2021-2023 | Verquvo |
| Reflow Medical INC | $135.55 | 2024 | |
| Esperion Therapeutics, INC. | $106.16 | 2021-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $104.07 | 2019-2024 | Farxiga |
| Kestra Medical Technology Services, INC. | $104.06 | 2023-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $85.39 | 2024-2025 | Onpattro |
| Novo Nordisk INC | $81.59 | 2022-2025 | Ozempic |
| Altathera Pharmaceuticals LLC | $47.50 | 2025 | Sotalol Hydrochloride |
| Genzyme Corporation | $46.88 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $44.10 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $38.09 | 2020-2021 | |
| Cardiofocus, INC. | $31.29 | 2023 | Heartlight System |
| Scpharmaceuticals INC. | $25.23 | 2023 | |
| Irhythm Technologies, INC. | $22.94 | 2023 | Zio Xt Patch |
| Bridgebio Pharma, INC. | $21.61 | 2025 | Attruby |
| Daiichi Sankyo INC. | $21.05 | 2022 | |
| Inspire Medical Systems, INC. | $20.45 | 2025 | Inspire |
| Chiesi USA, INC. | $19.95 | 2024 | Kengreal |
| Endologix LLC | $18.33 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.08 | 2023 | Evkeeza |
| Inogen, INC. | $17.66 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $16.78 | 2024 | Arcalyst |
| Cordis US Corp. | $15.97 | 2025 | Mynx Control Venous |
| Braemar Manufacturing, LLC | $15.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.70 | 2023 | |
| Arbor Pharmaceuticals, INC. | $13.94 | 2019 | |
| Kerecis Limited | $13.76 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kiniksa Pharmaceuticals, LTD. | $13.29 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.